These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 25110234)
1. Dichloroacetate prevents but not reverses the formation of neointimal lesions in a rat model of severe pulmonary arterial hypertension. Li B; Yan J; Shen Y; Liu Y; Ma Z Mol Med Rep; 2014 Oct; 10(4):2144-52. PubMed ID: 25110234 [TBL] [Abstract][Full Text] [Related]
2. Increased expression of hypoxia-inducible factor-1α in proliferating neointimal lesions in a rat model of pulmonary arterial hypertension. Yan J; Shen Y; Wang Y; Li BB Am J Med Sci; 2013 Feb; 345(2):121-8. PubMed ID: 22627259 [TBL] [Abstract][Full Text] [Related]
5. Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats. Nishimura T; Faul JL; Berry GJ; Vaszar LT; Qiu D; Pearl RG; Kao PN Am J Respir Crit Care Med; 2002 Nov; 166(10):1403-8. PubMed ID: 12406854 [TBL] [Abstract][Full Text] [Related]
6. Fluoxetine protects against monocrotaline-induced pulmonary arterial remodeling by inhibition of hypoxia-inducible factor-1α and vascular endothelial growth factor. Han DD; Wang Y; Zhang XH; Liu JR; Wang HL Can J Physiol Pharmacol; 2012 Apr; 90(4):445-54. PubMed ID: 22448962 [TBL] [Abstract][Full Text] [Related]
7. Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels. Michelakis ED; McMurtry MS; Wu XC; Dyck JR; Moudgil R; Hopkins TA; Lopaschuk GD; Puttagunta L; Waite R; Archer SL Circulation; 2002 Jan; 105(2):244-50. PubMed ID: 11790708 [TBL] [Abstract][Full Text] [Related]
8. ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats. Li G; Liu Y; Zhu Y; Liu A; Xu Y; Li X; Li Z; Su J; Sun L Lung; 2013 Aug; 191(4):327-36. PubMed ID: 23652350 [TBL] [Abstract][Full Text] [Related]
9. Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells. Nishimura T; Vaszar LT; Faul JL; Zhao G; Berry GJ; Shi L; Qiu D; Benson G; Pearl RG; Kao PN Circulation; 2003 Sep; 108(13):1640-5. PubMed ID: 12963647 [TBL] [Abstract][Full Text] [Related]
10. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering. Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214 [TBL] [Abstract][Full Text] [Related]
11. Iptakalim attenuates hypoxia-induced pulmonary arterial hypertension in rats by endothelial function protection. Zhu R; Bi LQ; Wu SL; Li L; Kong H; Xie WP; Wang H; Meng ZL Mol Med Rep; 2015 Aug; 12(2):2945-52. PubMed ID: 25936382 [TBL] [Abstract][Full Text] [Related]
12. [Expression of GATA6 gene in lung tissue of rat with pulmonary hypertension]. Liu B; Liu HM; Yu L; Sun XJ; Wei L; Wang XM; Zhou TF Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):864-7, 875. PubMed ID: 17236581 [TBL] [Abstract][Full Text] [Related]
13. Endothelial fate mapping in mice with pulmonary hypertension. Qiao L; Nishimura T; Shi L; Sessions D; Thrasher A; Trudell JR; Berry GJ; Pearl RG; Kao PN Circulation; 2014 Feb; 129(6):692-703. PubMed ID: 24201301 [TBL] [Abstract][Full Text] [Related]
14. Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation. Sahara M; Sata M; Morita T; Nakamura K; Hirata Y; Nagai R Circulation; 2007 Jan; 115(4):509-17. PubMed ID: 17242277 [TBL] [Abstract][Full Text] [Related]
16. Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension. Okada K; Tanaka Y; Bernstein M; Zhang W; Patterson GA; Botney MD Am J Pathol; 1997 Oct; 151(4):1019-25. PubMed ID: 9327735 [TBL] [Abstract][Full Text] [Related]
17. [Effect of triptolide on the expression of matrix metalloproteinases 2 and 9 in lungs of experimental pulmonary hypertension]. Wei L; Liu T; Liu B; Wang XM; Zhao L; Zhou TF Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):479-83. PubMed ID: 17937863 [TBL] [Abstract][Full Text] [Related]
18. Deficiency of NOX1/nicotinamide adenine dinucleotide phosphate, reduced form oxidase leads to pulmonary vascular remodeling. Iwata K; Ikami K; Matsuno K; Yamashita T; Shiba D; Ibi M; Matsumoto M; Katsuyama M; Cui W; Zhang J; Zhu K; Takei N; Kokai Y; Ohneda O; Yokoyama T; Yabe-Nishimura C Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):110-9. PubMed ID: 24233492 [TBL] [Abstract][Full Text] [Related]
19. Aspirin attenuates pulmonary arterial hypertension in rats by reducing plasma 5-hydroxytryptamine levels. Shen L; Shen J; Pu J; He B Cell Biochem Biophys; 2011 Sep; 61(1):23-31. PubMed ID: 21327581 [TBL] [Abstract][Full Text] [Related]
20. Triptolide attenuates pulmonary arterial hypertension and neointimal formation in rats. Faul JL; Nishimura T; Berry GJ; Benson GV; Pearl RG; Kao PN Am J Respir Crit Care Med; 2000 Dec; 162(6):2252-8. PubMed ID: 11112148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]